close search

New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India.

Das M, Mamnoon F, Mansoor H, Meneguim AC, Singh P, Shah I, Ravi S, Kalon S, Hossain FN, Ferlazzo G, Isaakidis P, Furin J, Acharya S, Thakur HP

VIEW FULL ARTICLE

  • Journal The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

  • Published 27 Apr 2021

  • Volume 24

  • ISSUE 12

  • Pagination 1265-1271

  • DOI 10.5588/ijtld.20.0165

Abstract

Based on one of the largest global cohorts of children and adolescents to receive new TB drugs, this study has shown that injectable-free regimens containing BDQ and/or DLM on ambulatory basis were effective and well-tolerated among children and adolescents and should be made routinely accessible to these vulnerable groups.